About the Authors
- Ruoxiang Wang
-
* E-mail: ruoxiang.wang@cshs.org
Affiliations Uro-Oncology Research, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, United States of America, Molecular Urology and Therapeutics, Department of Urology, Emory University School of Medicine, Atlanta, Georgia, United States of America
- Xiaojuan Sun
-
Affiliation Molecular Urology and Therapeutics, Department of Urology, Emory University School of Medicine, Atlanta, Georgia, United States of America
- Christopher Y. Wang
-
Affiliation Molecular Urology and Therapeutics, Department of Urology, Emory University School of Medicine, Atlanta, Georgia, United States of America
- Peizhen Hu
-
Affiliation Uro-Oncology Research, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
- Chia-Yi Chu
-
Affiliation Molecular Urology and Therapeutics, Department of Urology, Emory University School of Medicine, Atlanta, Georgia, United States of America
- Shurong Liu
-
Affiliation Molecular Urology and Therapeutics, Department of Urology, Emory University School of Medicine, Atlanta, Georgia, United States of America
- Haiyen E. Zhau
-
Affiliation Uro-Oncology Research, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
- Leland W. K. Chung
-
Affiliation Uro-Oncology Research, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California, United States of America
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: RW LWKC HEZ. Performed the experiments: RW XS CYW PH CYC SL. Analyzed the data: RW XS CYW PH CYC SL. Contributed reagents/materials/analysis tools: LWKC HEZ. Wrote the paper: RW CYW HEZ LWKC.